Advisor Group Holdings, Inc. Xencor Inc Transaction History

Advisor Group Holdings, Inc.

$42.1 Billion
Q1 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Xencor Inc stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 210 shares of XNCR stock, worth $1,915. This represents 0.0% of its overall portfolio holdings.

Number of Shares

210

Previous 49 328.57%

Holding current value

$1,915

Previous $1,000 100.0%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$10.64 - $24.13 $1,713 - $3,884	161 Added 328.57%	210 $2,000
Q4 2024 Jun 06, 2025	SELL	$19.43 - $26.84 $3,128 - $4,321	-161 Reduced 76.67%	49 $1,000
Q4 2024 Feb 07, 2025	BUY	$19.43 - $26.84 $272 - $375	14 Added 40.0%	49 $1,000
Q2 2024 Aug 13, 2024	SELL	$18.21 - $24.5 $3,368 - $4,532	-185 Reduced 84.09%	35 $0
Q1 2024 May 10, 2024	SELL	$18.65 - $26.52 $5,147 - $7,319	-276 Reduced 55.65%	220 $4,000
Q4 2023 Feb 12, 2024	SELL	$16.53 - $21.42 $2,810 - $3,641	-170 Reduced 25.53%	496 $10,000
Q3 2023 Nov 13, 2023	BUY	$20.08 - $25.39 $2,048 - $2,589	102 Added 18.09%	666 $13,000
Q2 2023 Aug 10, 2023	BUY	$24.77 - $29.9 $272 - $328	11 Added 1.99%	564 $14,000
Q1 2023 May 12, 2023	SELL	$25.95 - $36.95 $5,657 - $8,055	-218 Reduced 28.27%	553 $15,000
Q4 2022 Feb 10, 2023	BUY	$24.79 - $30.86 $1,660 - $2,067	67 Added 9.52%	771 $20,000
Q3 2022 Nov 14, 2022	BUY	$24.62 - $32.44 $5,711 - $7,526	232 Added 49.15%	704 $18,000
Q2 2022 Aug 10, 2022	SELL	$19.74 - $29.01 $2,428 - $3,568	-123 Reduced 20.67%	472 $13,000
Q1 2022 May 04, 2022	BUY	$26.68 - $41.63 $1,280 - $1,998	48 Added 8.78%	595 $16,000
Q3 2021 Nov 05, 2021	SELL	$30.65 - $35.68 $122 - $142	-4 Reduced 0.73%	547 $18,000
Q2 2021 Aug 02, 2021	BUY	$34.33 - $44.68 $6,145 - $7,997	179 Added 48.12%	551 $19,000
Q1 2021 May 13, 2021	BUY	$40.81 - $53.88 $571 - $754	14 Added 3.91%	372 $17,000
Q3 2020 Nov 12, 2020	BUY	$30.09 - $43.02 $1,895 - $2,710	63 Added 21.36%	358 $13,000
Q2 2020 Aug 14, 2020	SELL	$27.76 - $33.42 $120,839 - $145,477	-4,353 Reduced 93.65%	295 $10,000
Q1 2020 May 18, 2020	BUY	$20.69 - $37.79 $96,167 - $175,647	4,648 New	4,648 $139,000

Others Institutions Holding XNCR

# of Institutions

210

Shares Held

78.4M

Call Options Held

3.4K

Put Options Held

1.9K

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $544M
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Xencor Inc Transaction History